

Single-use Bioprocessing Material Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Single-use Bioprocessing Material market is experiencing robust growth, driven by increasing demand for efficient and cost-effective manufacturing solutions in the biopharmaceutical sector. As of 2023, the market size is estimated at approximately $6 billion, with significant expansion expected due to advancements in technology and rising biomanufacturing activities globally.
Request Sample Report
◍ Thermo Fisher Scientific (US)
◍ Danaher Corporation (US)
The single-use bioprocessing material market fosters growth through innovation, expanding product offerings, and enhancing efficiency in biomanufacturing. Companies leverage advanced technologies, strategic partnerships, and geographical outreach to compete.
Key players include:
◍ GE Healthcare (General Electric Company) (US)
◍ Sartorius Stedim Biotech S.A (France)
◍ Merck Millipore (Merck Group) (US)
◍ 3M Company (US)
◍ Eppendorf AG (Germany)
◍ Finesse Solutions, Inc. (US)
- Thermo Fisher Scientific: Approx. $40B revenue
- Danaher Corporation: Approx. $30B revenue
- GE Healthcare: Approx. $20B revenue
- Sartorius Stedim: Approx. $2.5B revenue
- Merck Millipore: Approx. $30B revenue
◍ Applikon Biotechnology B.V. (Netherlands)
◍ Cesco Bioengineering Co., Ltd. (Japan)
◍ Octane Biotech Inc. (Canada)
◍ PBS Biotech, Inc. (US)
◍ Meissner Filtration Products, Inc. (US)
◍ Sentinel Process Systems Inc. (US)
◍ CMC Biologics (Asahi Glass Co.) (Denmark)
Request Sample Report
Biopharmaceutical Manufacturers
◍ Life Science R&D and Academic Research Institutes
◍ Contract Research Organization & Manufacturers
◍ Others
Request Sample Report
Plastic
Silicone
Request Sample Report
$ X Billion USD